Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.

Franco Scaldaferri,Daniela Pugliese,Giuseppe Privitera,Sara Onali,Loris Riccardo Lopetuso,Gianenrico Rizzatti,Carlo Romano Settanni,M. Pizzoferrato,E. Schiavoni,Laura Turchini,Valeria Amatucci,D. Napolitano,Tiziana Bernabei,Vincenzina Mora,Lucrezia Laterza,Alfredo Papa,Luisa Guidi,Gian Lodovico Rapaccini,Antonio Gasbarrini,Alessandro Armuzzi

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.

2020

The coronavirus disease 2019 (COVID-19) pandemic is having a major clinical as well as organisational impact on the national health-care system in Italy, particularly in high-volume hospitals which...

Keywords:

Inflammatory bowel disease
severe acute respiratory syndrome coronavirus 2
Internal medicine
Pandemic
Medicine
Coronavirus disease 2019
2019 20 coronavirus outbreak
Intensive care medicine
MEDLINE

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations